- by Patricia Lightner

I read about a woman with Parkinson's disease who has a young daughter. She would rather have PD than submit to a cure via embryonic stem cell research. She mistakenly believes the research on embryonic stem cells takes the lives of babies.

Read Full Article

We've been watching an experimental gene therapy Parkinson's treatment being tested by Neurologix, a medical research company. Physicians at Columbia University have now published the results of their Phase I clinical trial in the medical journal The Lancet.

Read Full Article

- by Matt Nilsen

I was a little surprised when I read an article from England claiming a company had "come up with a cure for Parkinson's". We wish the story were true. But we are not ready to post a cure announcement yet. Let's explore the medication in question, Cogane.

Read Full Article

As we scan the horizon for a cure for Parkinson's disease, it is hard to know if any of the ideas or experiments out there will lead to a cure. For example, it is pretty easy to imagine a stem cell turning into a dopamine-producing cell, and reviving the brain's dopamine factories. But it is still such a long way to go before a scientist actually does it.

Read Full Article

You've undoubtedly read about Coenzyme Q10 or CoQ10 and its possible benefits for people with Parkinson's disease. We've written about it in one of our blogs. Scientists continue to explore whether a dose of 1,200 to 2,400 milligrams of CoQ10 each day can help slow the progression of Parkinson's disease. One study was encouraging, so the National Institutes of Health is conducting larger study to clearly define the benefit of CoQ10.

Read Full Article

Recently the journal, Movement Disorders, published a study that compared the outcomes of men and women after deep brain stimulation surgery or DBS. There were only 22 men and 16 women in the study. So, the results are not definitive in our opinion; but, they do offer a good guess.

Read Full Article

We suspect that the vast majority of our readers actually live with Parkinson's disease, or are close to someone who live with it. We doubt that many people are actively trying to prevent it. However, if you live with Parkinson's disease, there may be people close to you that lived in the same environment as you, or have many of your common genes. So, they may be living with some of the same risk factors as you. You may want to pass on good information that may help them prevent Parkinson's disease.

Read Full Article

Since 2000, the Parkinson's disease community has seen some evidence that people taking the dopamine agonist pramipexole (brand name Mirapex) run a higher risk of developing edema, or swelling in their feet and legs. Edema is caused by the accumulation of water in the tissues of the lower extremities. Past studies have estimated that 5 to 22 percent of Parkinson's disease patients taking pramipexole develop edema in their feet or legs.

Read Full Article

In the past, we've reported that ibuprofen may reduce the risk of Parkinson's disease, and we shared the news that caffeine consumption and smoking may reduce the risk of Parkinson's disease, too. Today a newly published study in the Archives of Neurology states that individuals with Parkinson's disease are less likely to smoke or consume high doses of caffeine. It also reports that people who took nonsteroidal anti-inflammatory drugs (like ibuprofen, Celebrex, aspirin, and Aleve) did not have a lower risk of developing Parkinson's disease.

Read Full Article

ST. PAUL, Minn - Yesterday a team of medical researchers led by Rajesh Pahsa, MD from the University of Kansas, released a study on the benefits of prolonged release ropinirole.

Read Full Article